RCM
CLX icon

Raleigh Capital Management’s Clorox CLX Stock Holding History

Raleigh Capital Management’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-97
Closed -$11.9K – 586
2025
Q3 		$11.9K Buy
97
+1
+1% +$124 ﹤0.01% 355
2025
Q2 		$11.5K Sell
96
-3
-3% -$400 ﹤0.01% 366
2025
Q1 		$14.5K Sell
99
-39
-28% -$5.96K 0.01% 344
2024
Q4 		$22.5K Buy
138
+100
+263% +$16.4K 0.01% 428
2024
Q3 		$6.24K Buy
38
+1
+3% +$148 ﹤0.01% 669
2024
Q2 		$5.07K Sell
37
-2
-5% -$278 ﹤0.01% 666
2024
Q1 		$5.97K Buy
39
+6
+18% +$896 ﹤0.01% 633
2023
Q4 		$4.73K Sell
33
-212
-87% -$28.3K ﹤0.01% 745
2023
Q3 		$32.1K Buy
245
+19
+8% +$2.89K 0.02% 314
2023
Q2 		$35.9K Sell
226
-6,131
-96% -$989K 0.02% 287
2023
Q1 		$1.01M Sell
6,357
-3,764
-37% -$564K 0.5% 63
2022
Q4 		$1.42M Buy
10,121
+905
+10% +$128K 0.74% 40
2022
Q3 		$1.18M Buy
9,216
+2,010
+28% +$290K 0.69% 47
2022
Q2 		$1.02M Buy
7,206
+4,507
+167% +$644K 0.58% 50
2022
Q1 		$375K Buy
2,699
+2,679
+13,395% +$411K 0.2% 123
2021
Q4 		$3K Buy
+20
New +$3.33K ﹤0.01% 259

Other funds holding CLX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Raleigh Capital Management's CLX Position: Q4 2025 in Review

Raleigh Capital Management sold out of Clorox (CLX) in Q4 2025, closing a stake of 97 shares — an estimated $11.9K sold.

Raleigh Capital Management first reported a position in CLX in Q4 2021 and held it in 16 quarters. The position peaked at $1.42M in Q4 2022. 1,052 funds tracked by Wall St. Rank hold CLX as of Q4 2025.

  • Raleigh Capital Management reported no remaining Clorox position as of Q4 2025 after selling out during the quarter.
  • Raleigh Capital Management sold 97 Clorox shares in Q4 2025, an estimated $11.9K.
  • Raleigh Capital Management first reported a position in Clorox in Q4 2021 and held it in 16 quarters.
  • Raleigh Capital Management's Clorox position peaked at $1.42M in Q4 2022.
  • 1,052 funds tracked by Wall St. Rank held Clorox as of Q4 2025.

Based on Raleigh Capital Management's 13F filing for Q4 2025, filed 21 Jan 2026.